Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: Implications for ischemic preconditioning

Basic Research in Cardiology

Volumn 95, Issue 1, 2000, Pages 1-10

  Aitchison, Keri A ^a   Baxter, Gary F ^b   Awan, M Moneeb ^a   Smith, Robert M ^a   Yellon, Derek M ^b   Opie, Lionel H ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Delta opioid receptor; Infarct size; Kappa opioid receptor; Preconditioning; Regional ischemia

Indexed keywords

BREMAZOCINE; CYCLIC AMP; CYCLIC GMP; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; NALTRINDOLE; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG MIXTURE; DRUG RECEPTOR BINDING; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; ISOLATED HEART; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

ANIMALS; HEMODYNAMIC PROCESSES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; RATS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; VENTRICULAR FIBRILLATION;

EID: 0034111658     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950050001     Document Type: Article

References (44)

1. Bian J-S, Zhang W-M, Wong TM (1998) Effects of κ-opioid receptor stimulation of the heart and the involvement of protein kinase C. Br J Pharmacol 124: 600-606
2. Bugge E, Ytrehus K (1995) Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart - a protective additive to ischaemic preconditioning. Cardiovasc Res 29: 269-274
3. 5]-enkephalin). J Thorac Cardiovasc Surg 107: 964-967
4. Corbett AD, Gillan MGC, Kosterlitz HW et al. (1984) Selectivities of opioid peptide analogs and antagonists at the d-receptor. Br J Pharmacol 83: 271-279
5. Du Toit E, McCarthy J, Miyashiro J et al. (1998) Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts. Br J Pharmacol 123: 1159-1167
6. Du Toit EF, Opie LH (1994) Antiarrhythmic properties of specific inhibitors of sarcoplasmic reticulum calcium ATPase in the isolated perfused rat heart after coronary artery ligation. J Am Coll Cardiol 23: 1505-1510
7. Holaday JW (1983) Cardiovascular effects of the endogenous opiate system. Annu Rev Pharmacol Toxicol 23: 541-594
8. Imagawa J, Baxter GF, Yellon DM (1997) Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. J Mol Cell Cardiol 29: 1885-1893
9. Law PY, McGinn TM, Campbell LE et al. (1997) Agonist activation of δ-opioid receptor but not μ-opioid receptor potentiates fetal calf serum of tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner. Mol Pharmacol 51: 152-160
10. Lee AY-S, Chen Y-T, Kan M-N et al. (1992) Consequences of opiate agonist and antagonist in myocardial ischaemia suggest a role of endogenous opioid peptides in ischaemic heart disease. Cardiovasc Res 26: 392-395
11. Lochner A, Genade S, Trompe E et al. (1998) Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning. Mol Cell Biochem 186: 169-175
12. Maulik N, Watanabe M, Zu Y et al. (1996) Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBBS lett 396: 233-237
13. Mayfield KP, D'Alecy LG (1994) Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther 268: 683-688
14. McIntosh M, Kane K, Parratt J (1992) Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia. Eur J Pharmacol 210: 37-44
15. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 74: 1124-1136
16. 2-adrenoceptor, GABAB and κ-opioid receptor agonists. Br J Pharmacol 110: 1049-1054
17. B, alpha, mu and kappa opioid receptors. J Pharmacol Exp Ther 276: 1136-1142
18. Parratt JR (1995) Possibilities for the pharmacological exploitation of ischaemic preconditioning. J Mol Cell Cardiol 27: 991-1000
19. Pepe S, Xiao R, Hohl C et al. (1997) "Cross-talk" between opioid peptide and adrenergic receptor signalling in isolated rat heart. Circulation 95: 2122-2129
20. Piper HM, Garcia-Dorado O, Ovize M (1998) A fresh look at reperfusion injury. Cardiovasc Res 38: 291-300
21. Portoghese PS, Lipowski AW, Takemori AE (1987) Binaltorphimine and nor-binaltorphimine potent and selective kappa opioid receptor antagonists. Life Sci 40: 1287-1292
22. ATP channel in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide. Am J Physiol 271: H23-H28
23. Romer D, Buscher H, Hill RC et al. (1980) Bremazocine: a potent, long-acting opiate kappa-agonist. Life Sci 27: 971-978
24. Sandhu R, Diaz RJ, Mao GD et al. (1997) Ischemic preconditioning. Differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia. Circulation 96: 984-995
25. Schultz JE, Rose E, Yao Z et al. (1995) Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Heart Circ Physiol 37: H2157-H2161
26. Schultz JJ, Hsu AK, Barbieri JT et al. (1998) Pertussis toxin abolishes the cardio-protective effect of ischemic preconditioning in the intact rat heart. Am J Physiol 275: H495-H500
27. Schultz JJ, Hsu AK, Gross GJ (1997) Ischemic preconditioning and morphine-induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 29: 2187-2195
28. 1-but not μ- or κ-opioid receptors. Circulation 97: 1282-1289
29. Schultz JJ, Hsu AK, Gross GJ (1997) Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol 29: 1355-1362
30. Schultz JJ, Hsu AK, Gross GJ (1996) Morphine mimics the cardioprotective effects of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78: 100-1104
31. ATP channels. Am J Physiol 274:H909-H914
32. Speechly-Dick ME, Mocanu MM, Yellon DM (1994) Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 75: 586-590
33. Standifer KM, Pasternak GW (1997) G proteins and opioid receptor-mediated signalling. Cell Signal 9: 237-248
34. Ventura C, Bastagli L, Bernadi P et al. (1989) Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoprotenerol. Biochim Biophys Acta 987: 69-74
35. 2+ in cardiac myocytes. Am J Physiol 261: H1671-H1674
36. Wild KD, Vanderah T, Mosberg HI et al. (1991) Opioid δ receptor subtypes are associated with different potassium channels. Eur J Pharmacol 193: 135-136
37. Wong TM, Lee AY, Tai KK (1990) Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart - an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 22: 1167-1175
38. Wu S, Li Y, Wong TM (1999) Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Circ Res 84: 1388-1395
39. Xia Q, Zhang W, Shen Y et al. (1996) Decreased affinity of kappa receptor binding during reperfusion following ischaemic preconditioning in the rat heart. Life Sci 58: 1307-1313
40. Yellon DM, Baxter GF, Garcia-Dorado D et al. (1998) Ischaemic preconditioning: present position and future directions. Cardiovasc Res 37: 21-33
41. Ytrehus K, Liu Y, Downey JM (1994) Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266: H1145-H1152
42. Yu X-C, Wang H-X, Pei J-M et al. (1999) Anti-arrhythmic effect of κ-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 31: 1809-1819
43. Zhang WM, Jin WQ, Wong TM (1996) Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma. J Mol Cell Cardiol 28: 1147-1154
44. 2+] and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart. J Mol Cell Cardiol 31: 355-362